Annalisa Milano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Annalisa Milano has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Aoife McMahon
European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK
3 shared publications - Connie R. Bezzina
Amsterdam Cardiovascular Sciences, Cardiomyopathy and Arrhythmia, Amsterdam, Netherlands
3 shared publications - Danielle Welter
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg, Luxembourg
3 shared publications Elisabeth M. Lodder
From the Department of Clinical & Experimental Cardiology, Heart Center, Amsterdam Medical Center, University of Amsterdam, Amsterdam, the Netherlands (A.M., M.T.B., E.M.L., D.A.v.H., J.B., T.T.K., A.B., L.B., A.A.M.W., C.R.B., H.L.T.); Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany; Institut für Humangenetik, Technische Universität München, Munich, Germany (P.L.); Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the...
3 shared publications- Emily Bowler-Barnett
EMBL-EBI
3 shared publications - Fiona Cunningham
European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK
3 shared publications
Latest Publications
- Open Access
- 5 November 2018
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 47 (D1) , D84-D88
The European Nucleotide Archive in 2018
The European Nucleotide Archive (ENA; https://www.ebi.ac.uk/ena), provided from EMBL-EBI, has for more than three decades been responsible for archiving the world's public sequencing data and presenting this important resource to the scientific community to support and accelerate the global research effort. Here, we outline ENA services and content in 2018 and provide an overview of a selection of focus areas of development work: extending data coordination services around ENA, sequence submissions through template expansion, early pre-submission validation tools and our move towards a new browser and retrieval infrastructure.
- 5 November 2018
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 47 (D1) , D84-D88
Open AccessThe European Nucleotide Archive in 2018
The European Nucleotide Archive (ENA; https://www.ebi.ac.uk/ena), provided from EMBL-EBI, has for more than three decades been responsible for archiving the world's public sequencing data and presenting this important resource to the scientific community to support and accelerate the global research effort. Here, we outline ENA services and content in 2018 and provide an overview of a selection of focus areas of development work: extending data coordination services around ENA, sequence submissions through template expansion, early pre-submission validation tools and our move towards a new browser and retrieval infrastructure.
- Open Access
- 15 February 2018
- Published by Springer Nature in Genome Biology
- Vol. 19 (1) , 1-10
A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
The accurate description of ancestry is essential to interpret, access, and integrate human genomics data, and to ensure that these benefit individuals from all ancestral backgrounds. However, there are no established guidelines for the representation of ancestry information. Here we describe a framework for the accurate and standardized description of sample ancestry, and validate it by application to the NHGRI-EBI GWAS Catalog. We confirm known biases and gaps in diversity, and find that African and Hispanic or Latin American ancestry populations contribute a disproportionately high number of associations. It is our hope that widespread adoption of this framework will lead to improved analysis, interpretation, and integration of human genomics data.
- 15 February 2018
- Published by Springer Nature in Genome Biology
- Vol. 19 (1) , 1-10
Open AccessA standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
The accurate description of ancestry is essential to interpret, access, and integrate human genomics data, and to ensure that these benefit individuals from all ancestral backgrounds. However, there are no established guidelines for the representation of ancestry information. Here we describe a framework for the accurate and standardized description of sample ancestry, and validate it by application to the NHGRI-EBI GWAS Catalog. We confirm known biases and gaps in diversity, and find that African and Hispanic or Latin American ancestry populations contribute a disproportionately high number of associations. It is our hope that widespread adoption of this framework will lead to improved analysis, interpretation, and integration of human genomics data.
- Open Access
A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
Background: The accurate description of ancestry is essential to interpret and integrate human genomics data, and to ensure that advances in the field of genomics benefit individuals from all ancestral backgrounds. However, there are no established guidelines for the consistent, unambiguous and standardized description of ancestry. To fill this gap, we provide a framework, designed for the representation of ancestry in GWAS data, but with wider application to studies and resources involving human subjects. Result: Here we describe our framework and its application to the representation of ancestry data in a widely-used publically available genomics resource, the NHGRI-EBI GWAS Catalog. We present the first analyses of GWAS data using our ancestry categories, demonstrating the validity of the framework to facilitate the tracking of ancestry in big data sets. We exhibit the broader relevance and integration potential of our method by its usage to describe the well-established HapMap and 1000 Genomes reference populations. Finally, to encourage adoption, we outline recommendations for authors to implement when describing samples. Conclusions: While the known bias towards inclusion of European ancestry individuals in GWA studies persists, African and Hispanic or Latin American ancestry populations contribute a disproportionately high number of associations, suggesting that analyses including these groups may be more effective at identifying new associations. We believe the widespread adoption of our framework will increase standardization of ancestry data, thus enabling improved analysis, interpretation and integration of human genomics data and furthering our understanding of disease.
Open AccessA standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
Background: The accurate description of ancestry is essential to interpret and integrate human genomics data, and to ensure that advances in the field of genomics benefit individuals from all ancestral backgrounds. However, there are no established guidelines for the consistent, unambiguous and standardized description of ancestry. To fill this gap, we provide a framework, designed for the representation of ancestry in GWAS data, but with wider application to studies and resources involving human subjects. Result: Here we describe our framework and its application to the representation of ancestry data in a widely-used publically available genomics resource, the NHGRI-EBI GWAS Catalog. We present the first analyses of GWAS data using our ancestry categories, demonstrating the validity of the framework to facilitate the tracking of ancestry in big data sets. We exhibit the broader relevance and integration potential of our method by its usage to describe the well-established HapMap and 1000 Genomes reference populations. Finally, to encourage adoption, we outline recommendations for authors to implement when describing samples. Conclusions: While the known bias towards inclusion of European ancestry individuals in GWA studies persists, African and Hispanic or Latin American ancestry populations contribute a disproportionately high number of associations, suggesting that analyses including these groups may be more effective at identifying new associations. We believe the widespread adoption of our framework will increase standardization of ancestry data, thus enabling improved analysis, interpretation and integration of human genomics data and furthering our understanding of disease.
- Top Cited PapersOpen Access
- 29 November 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 45 (D1) , D896-D901
The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
The NHGRI-EBI GWAS Catalog has provided data from published genome-wide association studies since 2008. In 2015, the database was redesigned and relocated to EMBL-EBI. The new infrastructure includes a new graphical user interface (www.ebi.ac.uk/gwas/), ontology supported search functionality and an improved curation interface. These developments have improved the data release frequency by increasing automation of curation and providing scaling improvements. The range of available Catalog data has also been extended with structured ancestry and recruitment information added for all studies. The infrastructure improvements also support scaling for larger arrays, exome and sequencing studies, allowing the Catalog to adapt to the needs of evolving study design, genotyping technologies and user needs in the future.
- 29 November 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 45 (D1) , D896-D901
Top Cited PapersOpen AccessThe new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
The NHGRI-EBI GWAS Catalog has provided data from published genome-wide association studies since 2008. In 2015, the database was redesigned and relocated to EMBL-EBI. The new infrastructure includes a new graphical user interface (www.ebi.ac.uk/gwas/), ontology supported search functionality and an improved curation interface. These developments have improved the data release frequency by increasing automation of curation and providing scaling improvements. The range of available Catalog data has also been extended with structured ancestry and recruitment information added for all studies. The infrastructure improvements also support scaling for larger arrays, exome and sequencing studies, allowing the Catalog to adapt to the needs of evolving study design, genotyping technologies and user needs in the future.
- 1 April 2016
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 9 (2) , 147-153
Sudden Cardiac Arrest and Rare Genetic Variants in the Community
Background—: Sudden cardiac arrest (SCA) ranks among the most common causes of death worldwide. Because SCA is most often lethal, yet mostly occurs in individuals without previously known cardiac disease, the identification of patients at risk for SCA could save many lives. In unselected SCA victims from the community, common genetic variants (which are not disease-causing per se, but may increase susceptibility to ventricular fibrillation) are found to be associated with increased SCA risk. However, whether rare genetic variants contribute to SCA risk in the community is largely unexplored. Methods and Results—: We here investigated the involvement of rare genetic variants in SCA risk at the population level by studying the prevalence of 6 founder genetic variants present in the Dutch population (PLN-p.Arg14del, MYBPC3-p.Trp792fsX17, MYBPC3-p.Arg943X, MYBPC3-p.Pro955fsX95, PKP2-p.Arg79X, and the Chr7q36 idiopathic ventricular fibrillation risk haplotype) in a cohort of 1440 unselected Dutch SCA victims included in the Amsterdam Resuscitation Study (ARREST). The six studied founder mutations were found to be more prevalent (1.1%) in the ARREST SCA cohort compared with an ethnically and geographically matched set of controls (0.4%, n=1379; P P <0.02). Conclusions—: This finding provides proof-of-concept for the notion that rare genetic variants contribute to some extent to SCA risk in the community.
- 1 April 2016
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 9 (2) , 147-153
Sudden Cardiac Arrest and Rare Genetic Variants in the Community
Background—: Sudden cardiac arrest (SCA) ranks among the most common causes of death worldwide. Because SCA is most often lethal, yet mostly occurs in individuals without previously known cardiac disease, the identification of patients at risk for SCA could save many lives. In unselected SCA victims from the community, common genetic variants (which are not disease-causing per se, but may increase susceptibility to ventricular fibrillation) are found to be associated with increased SCA risk. However, whether rare genetic variants contribute to SCA risk in the community is largely unexplored. Methods and Results—: We here investigated the involvement of rare genetic variants in SCA risk at the population level by studying the prevalence of 6 founder genetic variants present in the Dutch population (PLN-p.Arg14del, MYBPC3-p.Trp792fsX17, MYBPC3-p.Arg943X, MYBPC3-p.Pro955fsX95, PKP2-p.Arg79X, and the Chr7q36 idiopathic ventricular fibrillation risk haplotype) in a cohort of 1440 unselected Dutch SCA victims included in the Amsterdam Resuscitation Study (ARREST). The six studied founder mutations were found to be more prevalent (1.1%) in the ARREST SCA cohort compared with an ethnically and geographically matched set of controls (0.4%, n=1379; P P <0.02). Conclusions—: This finding provides proof-of-concept for the notion that rare genetic variants contribute to some extent to SCA risk in the community.
- 1 May 2015
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 82, 167-173
TNNI3K in cardiovascular disease and prospects for therapy
- 1 May 2015
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 82, 167-173
TNNI3K in cardiovascular disease and prospects for therapy
- Open Access
- 1 June 2013
- Published by Elsevier in Annals of Oncology
- Vol. 24 (suppl_4) , iv25
PD-0001 Can We Predict Time to Tumor Progression in Early Colorectal Cancer Patients Using CTCS Count?
Background: Colorectal cancer is the second most common cause of cancer-related death in Europe. Although significant improvements in the primary surgical and chemotherapeutic treatment, it has been estimated that approximately 30% of colorectal cancer patients develop metastases and die. Haematogenous spreading of tumor cells is a pivotal step in the metastatic process. Circulating tumor cells (CTCs) have potential ability to enter the circulation, invade the target organs and subsequently form metastases. Data suggest that the CTCs count before treatment is an independent predictor of progression free survival (PFS) and overall survival (OS) in patients with metastatic colorectal cancer, meanwhile their prognostic role in patients with early disease is uncertain.
- 1 June 2013
- Published by Elsevier in Annals of Oncology
- Vol. 24 (suppl_4) , iv25
Open AccessPD-0001 Can We Predict Time to Tumor Progression in Early Colorectal Cancer Patients Using CTCS Count?
Background: Colorectal cancer is the second most common cause of cancer-related death in Europe. Although significant improvements in the primary surgical and chemotherapeutic treatment, it has been estimated that approximately 30% of colorectal cancer patients develop metastases and die. Haematogenous spreading of tumor cells is a pivotal step in the metastatic process. Circulating tumor cells (CTCs) have potential ability to enter the circulation, invade the target organs and subsequently form metastases. Data suggest that the CTCs count before treatment is an independent predictor of progression free survival (PFS) and overall survival (OS) in patients with metastatic colorectal cancer, meanwhile their prognostic role in patients with early disease is uncertain.
- Open Access
- 6 December 2012
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 8 (12) , e1003113
Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
Atrio-ventricular conduction disease is a common feature in Mendelian rhythm disorders associated with sudden cardiac death and is characterized by prolongation of the PR interval on the surface electrocardiogram (ECG). Prolongation of the PR interval is also a strong predictor of atrial fibrillation, the most prevalent sustained cardiac arrhythmia. Despite the significant genetic component in PR duration variability, the genes regulating PR interval duration remain largely elusive. We here aimed to dissect the quantitative trait locus (QTL) for PR interval duration that we previously mapped in murine F2 progeny of a sensitized 129P2 and FVBN/J cross. To determine the underlying gene responsible for this QTL, genome-wide transcriptional profiling was carried out on myocardial tissue from 109 F2 mice. Expression QTLs (eQTLs) were mapped and the PR interval QTL was inspected for the co-incidence of eQTLs. We further determined the correlation of each of these transcripts to the PR interval. Tnni3k was the only eQTL, mapping to the PR-QTL, with an established abundant cardiac-specific expression pattern and a significant correlation to PR interval duration. Genotype inspection in various inbred mouse strains revealed the presence of at least three independent haplotypes at the Tnni3k locus. Measurement of PR interval duration and Tnni3k mRNA expression levels in six inbred lines identified a positive correlation between the level of Tnni3k mRNA and PR interval duration. Furthermore, in DBA/2J mice overexpressing hTNNI3K, and in DBA.AKR.hrtfm2 congenic mice, which harbor the AKR/J “high-Tnni3k expression” haplotype in the DBA/2J genetic background, PR interval duration was prolonged as compared to DBA/2J wild-type mice (“low-Tnni3k expression” haplotype). Our data provide the first evidence for a role of Tnni3k in controlling the electrocardiographic PR interval indicating a function of Tnni3k in atrio-ventricular conduction. Atrio-ventricular (AV) conduction disease (delay), characterized by prolongation of the PR interval on the surface electrocardiogram (ECG), is a common feature in Mendelian rhythm disorders and is associated with sudden cardiac death. Prolongation of the PR interval is also a strong predictor of atrial fibrillation (AF), the most common sustained cardiac arrhythmia. Although there is a substantial heritable component to the variability of the PR interval, the causative genes remain largely elusive. The identification of these genetic factors in the human population has been difficult owing to wide genetic heterogeneity and an uncontainable environment. We here exploited the homogeneous genetic background and controlled environment of inbred laboratory mouse strains to detect a genetic modifier of the PR interval. We identify Tnni3k as prime candidate for the modulation of the PR interval duration and suggest a new role for this gene, in the modulation of atrio-ventricular conduction.
- 6 December 2012
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 8 (12) , e1003113
Open AccessDissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
Atrio-ventricular conduction disease is a common feature in Mendelian rhythm disorders associated with sudden cardiac death and is characterized by prolongation of the PR interval on the surface electrocardiogram (ECG). Prolongation of the PR interval is also a strong predictor of atrial fibrillation, the most prevalent sustained cardiac arrhythmia. Despite the significant genetic component in PR duration variability, the genes regulating PR interval duration remain largely elusive. We here aimed to dissect the quantitative trait locus (QTL) for PR interval duration that we previously mapped in murine F2 progeny of a sensitized 129P2 and FVBN/J cross. To determine the underlying gene responsible for this QTL, genome-wide transcriptional profiling was carried out on myocardial tissue from 109 F2 mice. Expression QTLs (eQTLs) were mapped and the PR interval QTL was inspected for the co-incidence of eQTLs. We further determined the correlation of each of these transcripts to the PR interval. Tnni3k was the only eQTL, mapping to the PR-QTL, with an established abundant cardiac-specific expression pattern and a significant correlation to PR interval duration. Genotype inspection in various inbred mouse strains revealed the presence of at least three independent haplotypes at the Tnni3k locus. Measurement of PR interval duration and Tnni3k mRNA expression levels in six inbred lines identified a positive correlation between the level of Tnni3k mRNA and PR interval duration. Furthermore, in DBA/2J mice overexpressing hTNNI3K, and in DBA.AKR.hrtfm2 congenic mice, which harbor the AKR/J “high-Tnni3k expression” haplotype in the DBA/2J genetic background, PR interval duration was prolonged as compared to DBA/2J wild-type mice (“low-Tnni3k expression” haplotype). Our data provide the first evidence for a role of Tnni3k in controlling the electrocardiographic PR interval indicating a function of Tnni3k in atrio-ventricular conduction. Atrio-ventricular (AV) conduction disease (delay), characterized by prolongation of the PR interval on the surface electrocardiogram (ECG), is a common feature in Mendelian rhythm disorders and is associated with sudden cardiac death. Prolongation of the PR interval is also a strong predictor of atrial fibrillation (AF), the most common sustained cardiac arrhythmia. Although there is a substantial heritable component to the variability of the PR interval, the causative genes remain largely elusive. The identification of these genetic factors in the human population has been difficult owing to wide genetic heterogeneity and an uncontainable environment. We here exploited the homogeneous genetic background and controlled environment of inbred laboratory mouse strains to detect a genetic modifier of the PR interval. We identify Tnni3k as prime candidate for the modulation of the PR interval duration and suggest a new role for this gene, in the modulation of atrio-ventricular conduction.